top of page
Writer's pictureLester Davids

Aspen Pharmacare: Long Term Support At Risk - Tuesday, 10 September 2024

Pre-Market

Ticker: APN


  • The R240-250 range was rejected once again, in a similar manner to that seen in September 2021.

  • This level was previously support (which was followed by a multi-year breakdown) and has since become a resistance level.

  • The weekly candle structure remains poor which means that there is a risk of the multi-year incline being breached.

  • For short to medium term traders, the R160 level is a significant provisional re-accumulation level of interest.


APN Monthly Chart


 

Previous Post (05 September)

Pre-Market

Ticker: APN


  • Within the span of 19 months, the share has provided clients of Unum Capital with two opportunities to profit.

  • These opportunities came on both the long (buy) and short (sell) side, benefiting from a rising and falling share price.

  • The short leg provided short term traders with 3x opportunities to sell above 23500c.

  • Although the share briefly test the stop-loss level (a spike), the share pullback was in line with the view.

  • The updated chart, with the time-stamped ideas, is shown below.



Lester Davids

Analyst: Unum Capital


2 views0 comments

Comments


bottom of page